-
1
-
-
79958008114
-
What the pulmonary specialist should know about the new inhalation therapies
-
Laube BL, Janssens HM, de Jongh FHC, et al: What the pulmonary specialist should know about the new inhalation therapies. Eur Respir J 2011; 37: 1308-1331.
-
(2011)
Eur Respir J
, vol.37
, pp. 1308-1331
-
-
Laube, B.L.1
Janssens, H.M.2
De Jongh, F.H.C.3
-
2
-
-
13544253826
-
Device selection and outcomes of aerosol therapy: Evidence-based guidelines: American college of chest physicians/american college of asthma, allergy, and immunology
-
Dolovich MB, Ahrens Rc, Hess DR, et al: Device selection and outcomes of aerosol therapy: evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and Immunology. Chest 2005; 127: 335-371.
-
(2005)
Chest
, vol.127
, pp. 335-371
-
-
Dolovich, M.B.1
Rc, A.2
Hess, D.R.3
-
3
-
-
79952763932
-
Aerosol drug delivery: Developments in device design and clinical use
-
Dolovich MB, Dhand R: Aerosol drug delivery: developments in device design and clinical use. Lancet 2011: 377: 1032-1045.
-
(2011)
Lancet
, vol.377
, pp. 1032-1045
-
-
Dolovich, M.B.1
Dhand, R.2
-
4
-
-
84903551277
-
-
Global Initiative for Asthma: Global Strategy for Asthma Management and Prevention. updated December
-
Global Initiative for Asthma: Global Strategy for Asthma Management and Prevention. http://www.ginaasthma.com (updated December 2012).
-
(2012)
-
-
-
5
-
-
84903540904
-
-
Global Initiative for Chronic Obstructive Lung Disease: Global Strategy for Diagnosis, Management, and Prevention of COPD. update
-
Global Initiative for Chronic Obstructive Lung Disease: Global Strategy for Diagnosis, Management, and Prevention of COPD. http://www.goldcopd.org/ uploads/users/files/GOLD-Report-2011-Jan21.pdf (2011 update).
-
(2011)
-
-
-
6
-
-
84894506129
-
Improving inhaler technique, adherence to therapy and the precision of dosing: Major challenges for pulmonary drug delivery
-
Newman S: Improving inhaler technique, adherence to therapy and the precision of dosing: major challenges for pulmonary drug delivery. Expert Opin Drug Deliv 2014; 11: 365-378.
-
(2014)
Expert Opin Drug Deliv
, vol.11
, pp. 365-378
-
-
Newman, S.1
-
7
-
-
26944474854
-
Deposition of inhaled particles in the human respiratory tract and consequences for regional targeting in respiratory drug delivery
-
Heyder J: Deposition of inhaled particles in the human respiratory tract and consequences for regional targeting in respiratory drug delivery. Proc Am Thorac Soc 2004; 1: 315-320.
-
(2004)
Proc Am Thorac Soc
, vol.1
, pp. 315-320
-
-
Heyder, J.1
-
8
-
-
79957454222
-
Retail sales of inhalation devices in European countries: So much for a global policy
-
Lavorini F, Corrigan CJ, Barnes PJ, et al: Retail sales of inhalation devices in European countries: so much for a global policy. Respir Med 2011; 105: 1099-1113.
-
(2011)
Respir Med
, vol.105
, pp. 1099-1113
-
-
Lavorini, F.1
Corrigan, C.J.2
Barnes, P.J.3
-
9
-
-
79955499377
-
Cost-effectiveness of metered-dose inhalers for asthma exacerbations in the pediatric emergency department
-
Doan Q, Shefrin A, Johnson D: Cost-effectiveness of metered-dose inhalers for asthma exacerbations in the pediatric emergency department. Pediatrics 2011; 127: 1105-1111.
-
(2011)
Pediatrics
, vol.127
, pp. 1105-1111
-
-
Doan, Q.1
Shefrin, A.2
Johnson, D.3
-
10
-
-
34047146927
-
Withdrawal of albuterol inhalers containing chlorofluorocarbon propellants
-
Hendeles L, Colice GL, Meyer RJ: Withdrawal of albuterol inhalers containing chlorofluorocarbon propellants. N Engl J Med 2007; 356: 1344-1351.
-
(2007)
N Engl J Med
, vol.356
, pp. 1344-1351
-
-
Hendeles, L.1
Colice, G.L.2
Meyer, R.J.3
-
11
-
-
0032827577
-
Advances in metered dose inhaler technology with the development of a chlorofluorocarbon-free drug delivery system
-
Ross DL, Gabrio BJ: Advances in metered dose inhaler technology with the development of a chlorofluorocarbon-free drug delivery system. J Aerosol Med 1999; 12: 151-160.
-
(1999)
J Aerosol Med
, vol.12
, pp. 151-160
-
-
Ross, D.L.1
Gabrio, B.J.2
-
12
-
-
11144283302
-
Modulite: A means of designing the aerosols generated by pressurized metered dose inhalers
-
Ganderton D, Lewis D, Davies R, et al: Modulite: a means of designing the aerosols generated by pressurized metered dose inhalers. Respir Med 2002; 96(suppl D):S3-S8.
-
(2002)
Respir Med
, vol.96
, Issue.SUPPL. D
-
-
Ganderton, D.1
Lewis, D.2
Davies, R.3
-
13
-
-
33644621503
-
The CFC to HFA transition and its impact on pulmonary drug development
-
Leach CL: The CFC to HFA transition and its impact on pulmonary drug development. Respir Care 2005; 50: 1201-1208.
-
(2005)
Respir Care
, vol.50
, pp. 1201-1208
-
-
Leach, C.L.1
-
15
-
-
0032764740
-
A new method to evaluate plume characteristics of hydrofluoroalkane and chlorofluorocarbon metered dose inhalers
-
Gabrio BJ, Stein SW, Velasquez DJ: A new method to evaluate plume characteristics of hydrofluoroalkane and chlorofluorocarbon metered dose inhalers. Int J Pharm 1999; 186: 3-12.
-
(1999)
Int J Pharm
, vol.186
, pp. 3-12
-
-
Gabrio, B.J.1
Stein, S.W.2
Velasquez, D.J.3
-
16
-
-
33846999016
-
Advances in asthma and COPD management: Delivering CFC-free inhaled therapy using Modulite technology
-
Acerbi D, Brambilla G, Kottakis I: Advances in asthma and COPD management: delivering CFC-free inhaled therapy using Modulite technology. Pulm Pharmacol Ther 2007; 20: 290-303.
-
(2007)
Pulm Pharmacol Ther
, vol.20
, pp. 290-303
-
-
Acerbi, D.1
Brambilla, G.2
Kottakis, I.3
-
17
-
-
33747362898
-
Beclometasone dipropionate/formoterol: In an HFA-propelled pressurised metered-dose inhaler
-
Dhillon S, Keating GM: Beclometasone dipropionate/formoterol: in an HFA-propelled pressurised metered-dose inhaler. Drugs 2006; 66: 1475-1483.
-
(2006)
Drugs
, vol.66
, pp. 1475-1483
-
-
Dhillon, S.1
Keating, G.M.2
-
18
-
-
30444452988
-
Regional lung deposition and bronchodilator response as a function of beta2-agonist particle size
-
Usmani OS, Biddiscombe MF, Barnes PJ: Regional lung deposition and bronchodilator response as a function of beta2-agonist particle size. Am J Respir Crit Care Med 2005; 172: 1497-504.
-
(2005)
Am J Respir Crit Care Med
, vol.172
, pp. 1497-1504
-
-
Usmani, O.S.1
Biddiscombe, M.F.2
Barnes, P.J.3
-
19
-
-
84874342044
-
Prospective, open-label assessment of albuterol sulfate hydrofluoroalkane metered-dose inhaler with new integrated dose counter
-
Given J, Taveras H, Iverson H, Lepore M: Prospective, open-label assessment of albuterol sulfate hydrofluoroalkane metered-dose inhaler with new integrated dose counter. Allergy Asthma Proc 2013; 34: 42-51.
-
(2013)
Allergy Asthma Proc
, vol.34
, pp. 42-51
-
-
Given, J.1
Taveras, H.2
Iverson, H.3
Lepore, M.4
-
21
-
-
79957528899
-
Dose counter performance of mometasone furoate/formoterol inhalers in subjects with asthma or COPD
-
Weinstein C, Staudinger H, Scott I, Amar NJ, LaForce C: Dose counter performance of mometasone furoate/formoterol inhalers in subjects with asthma or COPD. Respir Med 2011; 105: 979-988.
-
(2011)
Respir Med
, vol.105
, pp. 979-988
-
-
Weinstein, C.1
Staudinger, H.2
Scott, I.3
Amar, N.J.4
Laforce, C.5
-
22
-
-
84880520454
-
Improving asthma management: The case for mandatory inclusion of dose counters on all rescue bronchodilators
-
Conner JB, Buck PO: Improving asthma management: the case for mandatory inclusion of dose counters on all rescue bronchodilators. J Asthma 2013; 50: 658-563.
-
(2013)
J Asthma
, vol.50
, pp. 658-563
-
-
Conner, J.B.1
Buck, P.O.2
-
23
-
-
33746347407
-
The need to improve inhalation technique in Europe: A report from the Aerosol Drug Management Improvement Team
-
Crompton GK, Barnes PJ, Broeder M, et al: The need to improve inhalation technique in Europe: a report from the Aerosol Drug Management Improvement Team. Respir Med 2006; 100: 1479-1494.
-
(2006)
Respir Med
, vol.100
, pp. 1479-1494
-
-
Crompton, G.K.1
Barnes, P.J.2
Broeder, M.3
-
24
-
-
0025951893
-
Improvement of drug delivery with a breath actuated pressurised aerosol for patients with poor inhaler technique
-
Newman SP, Weisz A, Talaee N, Clarke S: Improvement of drug delivery with a breath actuated pressurised aerosol for patients with poor inhaler technique. Thorax 1991; 46: 712-716.
-
(1991)
Thorax
, vol.46
, pp. 712-716
-
-
Newman, S.P.1
Weisz, A.2
Talaee, N.3
Clarke, S.4
-
25
-
-
29844448453
-
Influence of particle size and patient dosing technique on lung deposition of HFAbeclomethasone from a metered dose inhaler
-
Leach CL, Davidson PJ, Hasselquist BE, Boudreau RJ: Influence of particle size and patient dosing technique on lung deposition of HFAbeclomethasone from a metered dose inhaler. J Aerosol Med 2005; 18: 379-385.
-
(2005)
J Aerosol Med
, vol.18
, pp. 379-385
-
-
Leach, C.L.1
Davidson, P.J.2
Hasselquist, B.E.3
Boudreau, R.J.4
-
26
-
-
0032970171
-
Handling and acceptability of the Easi-Breathe device compared with a conventional metered dose inhaler by patients and practice nurses
-
Price DB, Pearce L, Powell SR, Shirley J, Sayers MK: Handling and acceptability of the Easi-Breathe device compared with a conventional metered dose inhaler by patients and practice nurses. Int J Clin Pract 1999; 53: 31-36.
-
(1999)
Int J Clin Pract
, vol.53
, pp. 31-36
-
-
Price, D.B.1
Pearce, L.2
Powell, S.R.3
Shirley, J.4
Sayers, M.K.5
-
27
-
-
0027978050
-
Reduction in patient timing errors using a breath-activated metered dose inhaler
-
Hampson NB, Mueller MP: Reduction in patient timing errors using a breath-activated metered dose inhaler. Chest 1994; 106: 462-465.
-
(1994)
Chest
, vol.106
, pp. 462-465
-
-
Hampson, N.B.1
Mueller, M.P.2
-
28
-
-
0034129205
-
Inappropriate inhaler use: Assessment of use and patient preference of seven inhalation devices
-
Lenny J, Innes J, Crompton GK: Inappropriate inhaler use: assessment of use and patient preference of seven inhalation devices. Respir Med 2000; 94: 496-500.
-
(2000)
Respir Med
, vol.94
, pp. 496-500
-
-
Lenny, J.1
Innes, J.2
Crompton, G.K.3
-
29
-
-
84908235237
-
Technological and practical challenges of dry powder inhalers and formulations
-
DOI: 10.1016/j.addr.2014.04.004
-
Hoppentocht M, Hagedoorn P, Frijlink HW, de Boer AH: Technological and practical challenges of dry powder inhalers and formulations. Adv Drug Deliv Rev 2014 DOI: 10.1016/j.addr.2014.04.004.
-
(2014)
Adv Drug Deliv Rev
-
-
Hoppentocht, M.1
Hagedoorn, P.2
Frijlink, H.W.3
De Boer, A.H.4
-
30
-
-
84862644228
-
Clarifying the dilemmas about inhalation techniques for dry powder inhalers: Integrating science with clinical practice
-
Azouz W, Chrystyn H: Clarifying the dilemmas about inhalation techniques for dry powder inhalers: integrating science with clinical practice. Prim Care Respir J 2012; 21: 208-213.
-
(2012)
Prim Care Respir J
, vol.21
, pp. 208-213
-
-
Azouz, W.1
Chrystyn, H.2
-
31
-
-
79961039597
-
Development of an inhaled dry-powder formulation of tobramycin using PulmoSphere TM technology
-
Geller DE, Weers J, Heuerding S: Development of an inhaled dry-powder formulation of tobramycin using PulmoSphere TM technology. J Aerosol Med Pulm Drug Deliv 2011; 24: 175-182.
-
(2011)
J Aerosol Med Pulm Drug Deliv
, vol.24
, pp. 175-182
-
-
Geller, D.E.1
Weers, J.2
Heuerding, S.3
-
32
-
-
0036586884
-
Evolution of dry powder inhaler design, formulation, and performance
-
Newman SP, Busse WW: Evolution of dry powder inhaler design, formulation, and performance. Respir Med 2002; 96: 293-304.
-
(2002)
Respir Med
, vol.96
, pp. 293-304
-
-
Newman, S.P.1
Busse, W.W.2
-
33
-
-
47049128164
-
Dry powder inhalers (DPIs)-A review of device reliability and innovation
-
Islam N, Gladki E: Dry powder inhalers (DPIs)-A review of device reliability and innovation. Int J Pharm 2008; 360: 1-11.
-
(2008)
Int J Pharm
, vol.360
, pp. 1-11
-
-
Islam, N.1
Gladki, E.2
-
34
-
-
33644644745
-
Dry powder inhalers: An overview
-
Atkins PJ: Dry powder inhalers: an overview. Respir Care 2005; 50: 1304-1312.
-
(2005)
Respir Care
, vol.50
, pp. 1304-1312
-
-
Atkins, P.J.1
-
35
-
-
78650181238
-
Inhaler devices what remains to be done
-
Smith IJ, Bell J, Bowman N, Everard M, Stein S, Weers JG: Inhaler devices: what remains to be done? J Aerosol Med Pulm Drug Deliv 2010; 23(suppl 2):S25-S37.
-
(2010)
J Aerosol Med Pulm Drug Deliv
, vol.23
, Issue.SUPPL. 2
-
-
Smith, I.J.1
Bell, J.2
Bowman, N.3
Everard, M.4
Stein, S.5
Weers, J.G.6
-
36
-
-
84903541658
-
Comparing usability of NEXThaler with other inhaled corticosteroid/long- acting β-agonist fixed combination dry powder inhalers in asthma patients
-
Epub ahead of print
-
Voshaar T, Spinola M, Linnane P, Campanini A, Lock D, Lafratta A, Scuri M, Ronca B, Melani AS: Comparing usability of NEXThaler with other inhaled corticosteroid/long-acting β2-agonist fixed combination dry powder inhalers in asthma patients. J Aerosol Med Pulm Drug Deliv 2013, Epub ahead of print.
-
(2013)
J Aerosol Med Pulm Drug Deliv
-
-
Voshaar, T.1
Spinola, M.2
Linnane, P.3
Campanini, A.4
Lock, D.5
Lafratta, A.6
Scuri, M.7
Ronca, B.8
Melani, A.S.9
-
37
-
-
84889041619
-
Qualitative assessment of attributes and ease of use of the ELLIPTA TM dry powder inhaler for delivery of maintenance therapy for asthma and COPD
-
Svedsater H, Dale P, Garrill K, Walker R, Woepse MW: Qualitative assessment of attributes and ease of use of the ELLIPTA TM dry powder inhaler for delivery of maintenance therapy for asthma and COPD. BMC Pulm Med 2013; 13: 72.
-
(2013)
BMC Pulm Med
, vol.13
, pp. 72
-
-
Svedsater, H.1
Dale, P.2
Garrill, K.3
Walker, R.4
Woepse, M.W.5
-
38
-
-
84857262977
-
The Genuair inhaler: A novel, multidose dry powder inhaler
-
Chrystyn H, Niederlaender C: The Genuair inhaler: a novel, multidose dry powder inhaler. Int J Clin Pract 2012; 66: 309-317.
-
(2012)
Int J Clin Pract
, vol.66
, pp. 309-317
-
-
Chrystyn, H.1
Niederlaender, C.2
-
39
-
-
70349932082
-
Lung deposition of aclidinium bromide from Genuair, a multidose dry powder inhaler
-
Newman SP, Sutton DJ, Segarra R, Lamarca R, de Miquel G: Lung deposition of aclidinium bromide from Genuair, a multidose dry powder inhaler. Respiration 2009; 78: 322-328.
-
(2009)
Respiration
, vol.78
, pp. 322-328
-
-
Newman, S.P.1
Sutton, D.J.2
Segarra, R.3
Lamarca, R.4
De Miquel, G.5
-
40
-
-
70350704823
-
Peak inspiratory flow through the Genuair inhaler in patients with moderate or severe COPD
-
Magnussen H, Watz H, Zimmermann I, et al: Peak inspiratory flow through the Genuair inhaler in patients with moderate or severe COPD. Respir Med 2009; 103: 1832-1837.
-
(2009)
Respir Med
, vol.103
, pp. 1832-1837
-
-
Magnussen, H.1
Watz, H.2
Zimmermann, I.3
-
41
-
-
84859735921
-
Developing an efficient and reliable dry powder inhaler for pulmonary drug delivery-A review for multidisciplinary researchers
-
Islam N, Cleary MJ: Developing an efficient and reliable dry powder inhaler for pulmonary drug delivery-A review for multidisciplinary researchers. Med Eng Phys 2012; 34: 409-427.
-
(2012)
Med Eng Phys
, vol.34
, pp. 409-427
-
-
Islam, N.1
Cleary, M.J.2
-
42
-
-
0030916624
-
The science of nebulised drug delivery
-
O'Callaghan C, Barry PW: The science of nebulised drug delivery. Thorax 1997; 52(suppl 2):S31-S44.
-
(1997)
Thorax
, vol.52
, Issue.SUPPL. 2
-
-
O'Callaghan, C.1
Barry, P.W.2
-
43
-
-
0033944036
-
Nebulizers: Principles and performance
-
Hess DR: Nebulizers: principles and performance. Respir Care 2000: 45: 609-622.
-
(2000)
Respir Care
, vol.45
, pp. 609-622
-
-
Hess, D.R.1
-
44
-
-
0034895786
-
European Respiratory Society Guidelines on the use of nebulizers
-
Boe J, Dennis JH, O'Driscoll BR, et al: European Respiratory Society Guidelines on the use of nebulizers. Eur Respir J 2001; 18: 228-242.
-
(2001)
Eur Respir J
, vol.18
, pp. 228-242
-
-
Boe, J.1
Dennis, J.H.2
O'Driscoll, B.R.3
-
45
-
-
0029763316
-
Medication nebulizer performance Effects of diluent volume, nebulizer flow, and nebulizer brand
-
Hess DR, Fisher D, Williams P, Pooler S, Kacmarek RM: Medication nebulizer performance. Effects of diluent volume, nebulizer flow, and nebulizer brand. Chest 1996; 110: 498-505.
-
(1996)
Chest
, vol.110
, pp. 498-505
-
-
Hess, D.R.1
Fisher, D.2
Williams, P.3
Pooler, S.4
Kacmarek, R.M.5
-
46
-
-
77953948906
-
Omron NE U22: Comparison between vibrating mesh and jet nebulizer
-
Skaria S, Smaldone GC: Omron NE U22: comparison between vibrating mesh and jet nebulizer. J Aerosol Med Pulm Drug Deliv 2010; 23: 173-180.
-
(2010)
J Aerosol Med Pulm Drug Deliv
, vol.23
, pp. 173-180
-
-
Skaria, S.1
Smaldone, G.C.2
-
47
-
-
0036885621
-
Nebulisers that use a vibrating mesh or plate with multiple apertures to generate aerosol
-
Dhand R: Nebulisers that use a vibrating mesh or plate with multiple apertures to generate aerosol. Respir Care 2002; 47: 1406-1416.
-
(2002)
Respir Care
, vol.47
, pp. 1406-1416
-
-
Dhand, R.1
-
48
-
-
79958238207
-
A comparison of amount and speed of deposition between the PARI LC STAR ® jet nebulizer and an investigational eFlow ® nebulizer
-
Coates AL, Green M, Leung K, et al: A comparison of amount and speed of deposition between the PARI LC STAR ® jet nebulizer and an investigational eFlow ® nebulizer. J Aerosol Med Pulm Drug Deliv 2011; 24: 157-163.
-
(2011)
J Aerosol Med Pulm Drug Deliv
, vol.24
, pp. 157-163
-
-
Coates, A.L.1
Green, M.2
Leung, K.3
-
49
-
-
0031425587
-
Adaptive aerosol delivery: The principles
-
Nikander K: Adaptive aerosol delivery: the principles. Eur Respir Rev 1999; 7: 385-387.
-
(1999)
Eur Respir Rev
, vol.7
, pp. 385-387
-
-
Nikander, K.1
-
50
-
-
0031425588
-
Adaptive aerosol delivery in practice
-
Denyer J: Adaptive aerosol delivery in practice. Eur Respir Rev 1997; 7: 388-389.
-
(1997)
Eur Respir Rev
, vol.7
, pp. 388-389
-
-
Denyer, J.1
-
51
-
-
33947508961
-
Delivery of iloprost inhalation solution with the halolite, prodose, and i-neb adaptive aerosol delivery systems: An in vitro study
-
Van Dyke RE, Nikander K: Delivery of iloprost inhalation solution with the HaloLite, Prodose, and I-neb adaptive aerosol delivery systems: an in vitro study. Respir Care 2007; 52: 184-190.
-
(2007)
Respir Care
, vol.52
, pp. 184-190
-
-
Van Dyke, R.E.1
Nikander, K.2
-
52
-
-
82255167120
-
Pediatric aerosol therapy: New devices and new drugs
-
Rubin BK: Pediatric aerosol therapy: new devices and new drugs. Respir Care 2011; 56: 1411-1421.
-
(2011)
Respir Care
, vol.56
, pp. 1411-1421
-
-
Rubin, B.K.1
-
53
-
-
69249120315
-
Lung deposition of inhaled alpha1-proteinase inhibitor in cystic fibrosis and alpha1-antitrypsin deficiency
-
Brand P, Schulte M, Wencker M, et al: Lung deposition of inhaled alpha1-proteinase inhibitor in cystic fibrosis and alpha1-antitrypsin deficiency. Eur Respir J 2009; 34: 354-360.
-
(2009)
Eur Respir J
, vol.34
, pp. 354-360
-
-
Brand, P.1
Schulte, M.2
Wencker, M.3
-
54
-
-
0042026773
-
Peripheral deposition of alpha-1 protease inhibitor using commercial inhalation devices
-
Brand P, Beckmann H, Maas Enriquez M, et al: Peripheral deposition of alpha-1 protease inhibitor using commercial inhalation devices. Eur Respir J 2003; 22: 262-267.
-
(2003)
Eur Respir J
, vol.22
, pp. 262-267
-
-
Brand, P.1
Beckmann, H.2
Maas Enriquez, M.3
-
55
-
-
84903545638
-
-
3-11 years with mild to moderate asthma (abstract). Chapel Hill, Congress of the International Society for Aerosols in Medicine
-
Mainz JG, Canisius S, Scheuch G, Mullinger B, Nocker K, Hofmann T: An open-label randomized pilot trial to evaluate tolerability, safety and applicability of budesonide inhalation suspension (BIS) delivered via AKITA JET in children aged 3-11 years with mild to moderate asthma (abstract). Chapel Hill, Congress of the International Society for Aerosols in Medicine, 2013.
-
(2013)
An Open-Label Randomized Pilot Trial to Evaluate Tolerability Safety and Applicability of Budesonide Inhalation Suspension (Bis) Delivered Via Akita Jet in Children Aged
-
-
Mainz, J.G.1
Canisius, S.2
Scheuch, G.3
Mullinger, B.4
Nocker, K.5
Hofmann, T.6
-
58
-
-
4444364706
-
A review of the development of Respimat soft mist inhaler
-
Dalby R, Spallek M, Voshaar T: A review of the development of Respimat soft mist inhaler. Int J Pharm 2004; 283: 1-9.
-
(2004)
Int J Pharm
, vol.283
, pp. 1-9
-
-
Dalby, R.1
Spallek, M.2
Voshaar, T.3
-
59
-
-
4344717797
-
A review of ipratropium bromide/fenoterol hydrobromide (Berodual) delivered via Respimat soft mist inhaler in patients with asthma and chronic obstructive pulmonary disease
-
Kassner F, Hodder R, Bateman ED: A review of ipratropium bromide/fenoterol hydrobromide (Berodual) delivered via Respimat soft mist inhaler in patients with asthma and chronic obstructive pulmonary disease. Drugs 2004; 64: 1671-1682.
-
(2004)
Drugs
, vol.64
, pp. 1671-1682
-
-
Kassner, F.1
Hodder, R.2
Bateman, E.D.3
-
60
-
-
40049096205
-
Effect of incorrect use of dry powder inhalers on management of patients with asthma and COPD
-
Lavorini F, Magnan A, Dubus JC, et al: Effect of incorrect use of dry powder inhalers on management of patients with asthma and COPD. Respir Med 2008; 102: 593-604.
-
(2008)
Respir Med
, vol.102
, pp. 593-604
-
-
Lavorini, F.1
Magnan, A.2
Dubus, J.C.3
-
61
-
-
77956792671
-
The chicago breathe project: A regional approach to improving education on asthma inhalers for resident physicians and minority patients
-
Press VG, Pincavage AT, Pappalardo AA: The Chicago Breathe Project: a regional approach to improving education on asthma inhalers for resident physicians and minority patients. J Natl Med Assoc 2010; 102: 548-555.
-
(2010)
J Natl Med Assoc
, vol.102
, pp. 548-555
-
-
Press, V.G.1
Pincavage, A.T.2
Pappalardo, A.A.3
-
62
-
-
0036178365
-
Misuse of corticosteroid metered-dose inhaler is associated with decreased asthma stability
-
Giraud V, Roche N: Misuse of corticosteroid metered-dose inhaler is associated with decreased asthma stability. Eur Respir J 2002; 19: 246-251.
-
(2002)
Eur Respir J
, vol.19
, pp. 246-251
-
-
Giraud, V.1
Roche, N.2
-
63
-
-
79955484156
-
Gruppo educazionale associazione italiana pneumologi ospedalieri inhaler mishandling remains common in real life and is associated with reduced disease control
-
Melani AS, Bonavia M, Cilenti V, Cinti C, Lodi M, Martucci P, Serra M, Scichilone N, Sestini P, Aliani M, Neri M: Gruppo Educazionale Associazione Italiana Pneumologi Ospedalieri. Inhaler mishandling remains common in real life and is associated with reduced disease control. Respir Med 2011; 105: 930-938.
-
(2011)
Respir Med
, vol.105
, pp. 930-938
-
-
Melani, A.S.1
Bonavia, M.2
Cilenti, V.3
Cinti, C.4
Lodi, M.5
Martucci, P.6
Serra, M.7
Scichilone, N.8
Sestini, P.9
Aliani, M.10
Neri, M.11
-
64
-
-
84888639007
-
Asthma patients' inability to use a pressurised metered-dose inhaler (pMDI) correctly correlates with poor asthma control as defined by the Global Initiative for Asthma (GINA) strategy: A retrospective analysis
-
Levy ML, Hardwell A, McKnight E, Holmes J: Asthma patients? inability to use a pressurised metered-dose inhaler (pMDI) correctly correlates with poor asthma control as defined by the Global Initiative for Asthma (GINA) strategy: a retrospective analysis. Prim Care Respir J 2013; 22: 406-411.
-
(2013)
Prim Care Respir J
, vol.22
, pp. 406-411
-
-
Levy, M.L.1
Hardwell, A.2
Mc Knight, E.3
Holmes, J.4
-
65
-
-
79551647479
-
ADMIT Working Group the ADMIT series-issues in inhalation therapy (6) Training tools for inhalation devices
-
Lavorini F, Levy ML, Corrigan C, Crompton G; ADMIT Working Group: The ADMIT series-issues in inhalation therapy. 6) Training tools for inhalation devices. Prim Care Respir J 2010; 19: 335-341.
-
(2010)
Prim Care Respir J
, vol.19
, pp. 335-341
-
-
Lavorini, F.1
Levy, M.L.2
Corrigan, C.3
Crompton, G.4
-
66
-
-
84871385237
-
Inhaler competence in asthma: Common errors, barriers to use and recommended solutions
-
Price D, Bosnic-Anticevich S, Briggs A, et al: Inhaler competence in asthma: common errors, barriers to use and recommended solutions. Respir Med 2013; 107: 37-46.
-
(2013)
Respir Med
, vol.107
, pp. 37-46
-
-
Price, D.1
Bosnic-Anticevich, S.2
Briggs, A.3
-
67
-
-
29744453224
-
Problems with inhaler use: A call for improved clinician and patient education
-
Fink JB, Rubin BK: Problems with inhaler use: a call for improved clinician and patient education. Respir Care 2005;50: 1360-1374.
-
(2005)
Respir Care
, vol.50
, pp. 1360-1374
-
-
Fink, J.B.1
Rubin, B.K.2
|